Examining Amarin Corp ADR (AMRN)’s cash flow and debt position

In the latest session, Amarin Corp ADR (NASDAQ: AMRN) closed at $1.21 down -0.82% from its previous closing price of $1.22. In other words, the price has decreased by -$0.0100 from its previous closing price. On the day, 684575 shares were traded. AMRN stock price reached its highest trading level at $1.2300 during the session, while it also had its lowest trading level at $1.2000.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Ratios:

For a deeper understanding of Amarin Corp ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.74 and its Current Ratio is at 2.69. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 22 when Holt Patrick bought 14,426 shares for $1.09 per share. The transaction valued at 15,724 led to the insider holds 314,426 shares of the business.

Ketchum Steven B sold 34,131 shares of AMRN for $26,963 on Dec 12. The Chief Scientific Officer now owns 566,100 shares after completing the transaction at $0.79 per share. On Aug 16, another insider, Holt Patrick, who serves as the President and CEO of the company, bought 300,000 shares for $1.04 each. As a result, the insider paid 312,315 and bolstered with 300,000 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMRN now has a Market Capitalization of 494.03M and an Enterprise Value of 182.34M. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.53 while its Price-to-Book (P/B) ratio in mrq is 0.89. Its current Enterprise Value per Revenue stands at 0.57 whereas that against EBITDA is -2.60.

Stock Price History:

Over the past 52 weeks, AMRN has reached a high of $2.17, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is 1.0410, while the 200-Day Moving Average is calculated to be 1.0310.

Shares Statistics:

For the past three months, AMRN has traded an average of 2.34M shares per day and 1.13M over the past ten days. A total of 408.55M shares are outstanding, with a floating share count of 406.72M. Insiders hold about 0.45% of the company’s shares, while institutions hold 23.56% stake in the company. Shares short for AMRN as of Jan 31, 2024 were 14.4M with a Short Ratio of 6.14, compared to 13.62M on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 3.53% and a Short% of Float of 3.54%.

Earnings Estimates

There are 4 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.03 for the current quarter, with a high estimate of -$0.03 and a low estimate of -$0.03, while EPS last year was $0. The consensus estimate for the next quarter is -$0.03, with high estimates of -$0.01 and low estimates of -$0.04.

Analysts are recommending an EPS of between -$0.16 and -$0.17 for the fiscal current year, implying an average EPS of -$0.16. EPS for the following year is -$0.15, with 4 analysts recommending between -$0.05 and -$0.19.

Revenue Estimates

A total of 5 analysts believe the company’s revenue will be $63.81M this quarter.It ranges from a high estimate of $71.1M to a low estimate of $60.8M. As of the current estimate, Amarin Corp ADR’s year-ago sales were $90.25M, an estimated decrease of -29.30% from the year-ago figure. For the next quarter, 3 analysts are estimating revenue of $58.93M, a decrease of -27.50% over than the figure of -$29.30% in the same quarter last year. There is a high estimate of $64.1M for the next quarter, whereas the lowest estimate is $51.6M.

A total of 5 analysts have provided revenue estimates for AMRN’s current fiscal year. The highest revenue estimate was $303.3M, while the lowest revenue estimate was $293M, resulting in an average revenue estimate of $295.94M. In the same quarter a year ago, actual revenue was $369.19M, down -19.80% from the average estimate. Based on 4 analysts’ estimates, the company’s revenue will be $226M in the next fiscal year. The high estimate is $265.5M and the low estimate is $199.39M. The average revenue growth estimate for next year is down -23.60% from the average revenue estimate for this year.

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular